Screening for Intracranial Aneurysm in Patients with Coarctation: Is It Cost-Effective?

Patients with a history of coarctation of the aorta have a higher prevalence of intracranial aneurysm and frequently suffer subarachnoid hemorrhage at younger ages than the general population.

Buscar aneurismas cerebrales en pacientes con coartación ¿Es costo/efectivo?

The American Heart Association (AHA) and American College of Cardiology (ACC) guidelines recommend intracranial aneurysm screening, but appropriate age and interval of screening remain an uncertainty.

The primary endpoint was to determine the best cost-effectiveness ratio, while secondary endpoints included the incidence of aneurysms with prophylactic treatment and prevented deaths that would have been caused by subarachnoid hemorrhage.

In a simulated cohort of 10,000 patients, researchers estimated a 10.1% lifetime cumulative risk of subarachnoid hemorrhage, which would cause 183 deaths.

A systematic resonance angiography screening at ages 10, 20, and 30 would result in prophylactic treatment for 978 unruptured aneurysms, 19 procedure-related deaths, and 65 subarachnoid-hemorrhage-related deaths.


Read also: FREEDOM with FFR: Different Outcomes?


Adding a screening stage at age 30—instead of just at ages 10 and 20—is cost-effective. Known data about the prognosis of a scheduled aneurysm embolization, when compared to the uncertainty of life quality after a subarachnoid hemorrhage, tilt the scales in favor of adopting a systematic screening approach as the best option.

Conclusion

This probabilistic model supports the AHA/ACC guidelines regarding systematic resonance angiography screening in patients with coarctation of the aorta.

Screening at ages 10, 20, and 30 is cost-effective and increases life expectancy.

Original Title: Screening for Intracranial Aneurysms in Coarctation of the Aorta. A Decision and Cost-Effectiveness Analysis.

Reference: Sarah S. Pickard et al. Circ Cardiovasc Qual Outcomes. 2020;13:e006406. DOI: 10.1161/CIRCOUTCOMES.119.006406.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

TCT 2024 | PEERLESS: Mechanical Thrombectomy with FlowTriever vs Catheter-Directed Thrombolysis in Intermediate Risk PTE

Pulmonary embolism (PE) continues to be the third cause of cardiovascular mortality. The current clinical guidelines recommend anticoagulation in intermediate risk patients presenting right...

Atherosclerotic Renal Artery Stenosis: To Revascularize or Not

At long term, atherosclerotic renal artery stenosis (RAS) can lead to hypertension, chronic kidney disease, and cardiac failure. Historically, these patients have been referred...

Endovascular Management of Chronic TEPH: Is Coronary Management Extrapolatable in This Scenario?

Chronic thromboembolic pulmonary hypertension (CTEPH) is a condition that causes significant functional limitation. Its surgical treatment, known as pulmonary endarterectomy (PEA), has improved the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...